Normal intelligence in children with prenatal exposure to carbamazepine

E Gaily1, E Kantola-Sorsa, V Hiilesmaa

  • 1Hospital for Children and Adolescents, 00029 HUS, Finland. eija.gaily@hus.fi

Neurology
|January 14, 2004
PubMed

Insights

Prenatal exposure to carbamazepine monotherapy did not affect child intelligence. However, valproate and polytherapy antiepileptic drug exposure were linked to lower verbal IQ scores in children.

Area of Science:

  • Neuroscience
  • Developmental Pediatrics
  • Pharmacology

Background:

  • Epilepsy affects women of childbearing age.
  • Antiepileptic drugs (AEDs) are crucial for seizure control but may pose risks to fetal development.
  • Understanding the neurodevelopmental effects of specific AEDs is vital for informed treatment decisions.

Purpose of the Study:

  • To evaluate the impact of prenatal exposure to specific antiepileptic drugs, namely carbamazepine and valproate, on the intelligence of children born to mothers with epilepsy.
  • To compare intelligence outcomes between children exposed to monotherapy, polytherapy, and unexposed controls.

Main Methods:

  • A cohort study involving 182 children exposed prenatally to AEDs and 141 control children.
  • Intelligence was assessed using the Wechsler Preschool and Primary Scale of Intelligence-Revised or Wechsler Intelligence Scale for Children-Revised in a blinded manner.
  • Maternal AED treatment, seizure history, and drug levels were prospectively collected.

Main Results:

  • Children exposed to carbamazepine monotherapy showed no significant difference in verbal or nonverbal IQ compared to controls.
  • Significantly lower verbal IQ scores were observed in children exposed prenatally to valproate monotherapy and to polytherapy.
  • Maternal serum levels of carbamazepine were within the reference range for monotherapy cases.

Conclusions:

  • Carbamazepine monotherapy, within therapeutic ranges, appears safe regarding offspring intelligence.
  • Prenatal exposure to valproate and polytherapy AEDs is associated with impaired verbal intelligence in children.
  • Further research is needed to confirm the independent effects of valproate due to confounding factors like maternal education and polytherapy.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Environmental Influences on Intelligence01:29

Environmental Influences on Intelligence

Despite the strong genetic influence on traits like intelligence, environmental factors significantly shape outcomes. For example, while over 90% of height variation is due to genetic differences, environmental factors such as nutrition also have a notable impact. Similarly, for intelligence, changes in a child's surroundings can significantly alter their IQ. Research shows that enriched environments boost children's academic success and help them develop key cognitive skills. Children from...
Intellectual Disability01:29

Intellectual Disability

Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...